Carolyn Fritz, M.B.A has over twenty years of experience in successfully building industrial biotechnology businesses. As part of the Afingen team, she advises strategy and commercialization plans to penetrate the markets and build the company. Kenneth Davenport, Ph.D. is an agricultural industry veteran, having served in leadership and executive capacities as Vice President of Strategy & CTO of Chromatin, Inc., Director of New Business Ventures with Bayer CropScience, GmbH, and CEO of ArborGen, LLC. As part of the Afingen team, he places particular emphasis on Afingen’s product development; regulatory, intellectual property and out-licensing strategies; and approaches to third-party leaders in the ag-biotech, planting seed, and related industries. Source: https://afingen.tech/our-team/